Edition:
United Kingdom

Pieris Pharmaceuticals Inc (PIRS.OQ)

PIRS.OQ on NASDAQ Stock Exchange Capital Market

2.65USD
18 Jan 2019
Change (% chg)

$-0.05 (-1.85%)
Prev Close
$2.70
Open
$2.70
Day's High
$2.80
Day's Low
$2.63
Volume
137,679
Avg. Vol
110,940
52-wk High
$9.69
52-wk Low
$2.40

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 8.35 -0.114
Jun '18 11.69 -0.004
Mar '18 4.15 -0.174
FY 2017 Dec '17 18.15 0.167
Sep '17 3.93 -0.159
Jun '17 1.85 -0.232
Mar '17 1.34 -0.186
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-19 2 6.25 6.70 5.80 2.30
Quarter Ending Jun-19 2 5.38 6.70 4.05 2.30
Year Ending Dec-19 4 22.24 31.00 12.00 11.28
Earnings (per share)
Quarter Ending Mar-19 1 -0.18 -0.18 -0.18 --
Quarter Ending Jun-19 1 -0.19 -0.19 -0.19 --
Year Ending Dec-19 3 -0.81 -0.62 -1.07 -0.74
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 69.71 33.71
P/E High - Last 5 Yrs. -- 148.01 49.93
P/E Low - Last 5 Yrs. -- 47.79 24.27
Beta -- 1.08 0.90
Price to Sales (TTM) 41.16 49.51 6.28
Price to Book (MRQ) 29.26 10.16 5.27
Price to Tangible Book (MRQ) 29.57 13.82 6.79
Price to Cash Flow (TTM) -- 52.80 24.84
% Owned Institutions 50.96 3.75 1.69

Dividends

  Company industry sector
Dividend Yield -- 0.12 1.40
Dividend Yield - 5 Year Avg -- 0.09 1.42
Dividend 5 Year Growth Rate -- 0.79 4.83
Payout Ratio(TTM) -- 7.04 41.08

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 72.70 130.03 9.72
Sales (TTM) vs TTM 1 Yr. Ago 37.63 47.85 5.87
Sales - 5 Yr. Growth Rate -- 22.76 11.20
EPS (MRQ) vs Qtr. 1 Yr. Ago -61.36 75.87 47.26
EPS (TTM) vs TTM 1 Yr. Ago -69.16 -- --
EPS - 5 Yr. Growth Rate -- 12.03 10.82
Capital Spending - 5 Yr. Growth Rate -- 9.24 15.18

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.18 2.26
Current Ratio (MRQ) 2.87 3.43 3.08
LT Debt to Equity (MRQ) 0.00 18.73 11.38
Total Debt to Equity (MRQ) 0.00 31.43 16.13
Interest Coverage (TTM) -92.13 -43.27 29.51

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.29 53.78
Gross Margin - 5 Yr. Avg. -- 60.55 52.17
EBITD Margin (TTM) -417.27 -- --
EBITD - 5 Yr. Avg -- -110.23 12.87
Operating Margin (TTM) -424.61 -184.42 6.20
Operating Margin - 5 Yr. Avg. -- -126.67 8.31
Pre-Tax Margin (TTM) -445.15 -175.20 7.17
Pre-Tax Margin - 5 Yr. Avg. -- -132.83 8.61
Net Profit Margin (TTM) -459.70 -181.93 3.30
Net Profit Margin - 5 Yr. Avg. -- -137.23 4.88
Effective Tax Rate (TTM) -- 21.48 22.88
Effective Tax Rate - 5 Yr. Avg. -- 15.57 23.39

Efficiency

  Company industry sector
Revenue/Employee (TTM) 136,884 7,650,695 844,239,566
Net Income/Employee (TTM) -629,254 652,572 100,064,145
Receivable Turnover (TTM) -- 6.25 5.72
Inventory Turnover (TTM) -- 1.89 3.48
Asset Turnover (TTM) 0.09 0.32 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -40.46 6.45 11.08
Return on Assets - 5 Yr. Avg. -- 5.52 12.21
Return on Investment (TTM) -55.96 8.99 14.48
Return on Investment - 5 Yr. Avg. -- 6.85 15.88
Return on Equity (TTM) -132.26 10.13 15.99
Return on Equity - 5 Yr. Avg. -- 8.39 17.00
  1 Year 3 Year 5 Year
Sales % 98.87 -22.30 --
EPS (TTM) % -33.71 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Pieris Pharmaceuticals Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 16.89 12.86 78 99
13 Week 7.41 2.18 61 95
26 Week 162.87 142.89 97 98
52 Week 264.33 208.80 96 72
YTD 343.35 289.35 98 72
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 67.27%
# of Holders: 139
Total Shares Held: 36,427,132
3 Mo. Net Change: 222,519
# New Positions: 4
# Closed Positions: 1
# Increased Positions: 7
# Reduced Positions: 7
# Net Buyers: 0
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.